Maynard Um
-
-
-
-
-
-
-
HSBC Upgrades Novartis (NOVN:SW) (NVS) to Hold
-
-
-
-
-
-
-
Novartis MS drug remibrutinib meets Phase III trial goals
-
-
-
-
-
-
-
Antares Therapeutics and Novartis team up on cancer drug discovery
-
-
-
-
-
-
-
China holds roundtable with over 50 foreign pharmaceutical firms
-
-
-
-
-
-
-
Novartis expands health programs to reach underserved communities globally
-
-
-
-
-
-
-
Argus Upgrades Novartis (NVS) to Buy
-
-
-
-
-
-
-
FDA grants Breakthrough Therapy status to Novartis ianalumab for Sjögren's
-
452,256 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

